Published in Epilepsia on January 01, 1997
Epilepsy related to hypothalamic hamartomas: surgical management with special reference to gamma knife surgery. Childs Nerv Syst (2006) 1.07
L-Type calcium channel blockade reduces network activity in human epileptic hypothalamic hamartoma tissue. Epilepsia (2011) 0.83
Gelastic seizures and fever originating from a parietal cortical dysplasia. J Pediatr Neurosci (2013) 0.78
Case of a child with gelastic seizures and hypothalamic hamartoma. Epilepsia (1997) 0.76
Case of a child with gelastic seizures and hypothalamic hamartoma. Epilepsia (1997) 0.75
Pathological Laughter, Multiple Sclerosis, Behavioural Abnormality. Med J Armed Forces India (2011) 0.75
Endoscopic Treatment of Hypothalamic Hamartomas. J Korean Neurosurg Soc (2017) 0.75
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Genomic instability in Gadd45a-deficient mice. Nat Genet (1999) 3.01
Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology (2002) 2.16
Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol (2001) 2.06
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax (1991) 1.86
Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology (1997) 1.85
Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology (2005) 1.85
Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group. Neurology (1999) 1.67
Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes (2000) 1.58
What is the relationship between arachnoid cysts and seizure foci? Epilepsia (1997) 1.58
Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care (2000) 1.56
The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry (2010) 1.53
Ubiquitin in cerebral amyloid angiopathy. J Neurol Sci (1992) 1.50
Cyclosporine-associated mutism in liver transplant patients. Neurology (1996) 1.49
Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology (1992) 1.47
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. Ann Intern Med (1995) 1.47
Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 1.47
BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol (1999) 1.46
Deleterious effect of dithizone-DMSO staining on insulin secretion in rat and human pancreatic islets. Pancreas (1994) 1.45
Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial). Int J Obes (Lond) (2010) 1.42
[Insulin secretion and insulin sensitivity in relation to glucose tolerance in a group of subjects at a high risk for type 2 diabetes mellitus]. Med Clin (Barc) (2001) 1.42
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol (2001) 1.39
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. AIDS (1999) 1.34
Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol (2007) 1.32
Accommodation-dependent model of the human eye with aspherics. J Opt Soc Am A (1985) 1.32
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int (2001) 1.30
The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry (2006) 1.25
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes (1998) 1.23
Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann Neurol (2000) 1.22
Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology (1994) 1.20
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod (2001) 1.19
Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology (1993) 1.18
Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke (1995) 1.17
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain (2005) 1.14
Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene (1993) 1.14
Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain (1999) 1.14
Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology (1986) 1.14
Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study. Am Rev Respir Dis (1990) 1.12
Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes. Diabetes Care (2000) 1.12
Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Ann Neurol (2001) 1.12
Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol (2001) 1.11
Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol (1999) 1.11
Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab (1983) 1.10
Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol (2000) 1.08
Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology (1993) 1.08
Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta. Clin Exp Immunol (2008) 1.07
Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology (1998) 1.07
The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes (1997) 1.06
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod (2000) 1.06
Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am J Hum Genet (1996) 1.06
Meige syndrome: neuropathology of a case. Mov Disord (1988) 1.05
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Parkinsonism and basal ganglia infarcts. Neurology (1984) 1.05
Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study. Eur J Nucl Med (1996) 1.04
Distinctive abnormalities of facial reflexes in patients with progressive supranuclear palsy. Brain (1997) 1.03
Bone scintigraphy and metabolic disorders. Q J Nucl Med (1999) 1.03
Determination of the point-spread function of human eyes using a hybrid optical-digital method. J Opt Soc Am A (1987) 1.03
Relationship between 25-(OH) D3, the IGF-I system, leptin, anthropometric and body composition variables in a healthy, randomly selected population. Horm Metab Res (2004) 1.02
Costochondral involvement in systemic candidiasis in heroin addicts: clinical, scintigraphic, and histologic features in 26 patients. Arthritis Rheum (1988) 1.01
A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J Neurol Sci (1983) 1.01
Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res (2001) 1.01
Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients. Neurosci Lett (1997) 1.00
Habituation of the auditory startle reaction is reduced during preparation for execution of a motor task in normal human subjects. Brain Res (1997) 1.00
Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy. Clin Infect Dis (2000) 1.00
Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet (2000) 1.00
Decreased frontal choline and neuropsychological performance in preclinical Huntington disease. Neurology (2007) 1.00
Giant-cell arteritis presenting with ipsilateral hemiplegia and lateral medullary syndrome. Eur Neurol (1989) 0.99
Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol (2007) 0.99
Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol (1996) 0.97
European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. Eur J Nucl Med Mol Imaging (2002) 0.97
Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology (2004) 0.97
The eye of the tiger sign in cortical-basal ganglionic degeneration. Mov Disord (1999) 0.96
Transient immunologic defect in a case of Listeria rhombencephalitis. Arch Neurol (1987) 0.95
Clinical comparison of dexketoprofen trometamol and dipyrone in postoperative dental pain. J Clin Pharmacol (1998) 0.95
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Eur J Neurol (2009) 0.95
Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes. Clin Exp Immunol (1993) 0.95
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. Eur J Nucl Med Mol Imaging (2002) 0.95
Effects of a startling acoustic stimulus on reaction time in different parkinsonian syndromes. Neurology (1998) 0.94
Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry (2002) 0.93
Trihalomethanes in water supplies in the San Sebastian area, Spain. Bull Environ Contam Toxicol (1994) 0.93
Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose. Diabet Med (2003) 0.93
Cerebral malformation induced by prenatal X-irradiation: an autoradiographic and Golgi study. J Anat (1984) 0.92
Focal limb dystonia. Eur J Neurol (2010) 0.92